<DOC>
	<DOCNO>NCT02372526</DOCNO>
	<brief_summary>The purpose study determine type macronutrient ( carbohydrate , lipid protein ) potently stimulate endogen secretion different gut hormone ( primary outcome = Glucagon-Like peptide-1 ) gastric bypass operate patient . The study also include comparison secretion gut hormones oral intake lipid without pancreatic lipase inhibitor .</brief_summary>
	<brief_title>The Effect Different Macronutrients Gastrointestinal Hormone Secretion After Gastric Bypass Operation</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<criteria>RYGB Patients : Underwent RYGB surgery 18 month earlier , weight stabile ( +/ 5 kg 1 month ) Inadequate thyroid substitution , undergo treatment drug know interact Orlistat ( cyclosporine , anticoagulating agent , amiodarone , amlodipine epileptic ) , pause treatment option . Type 1 2 diabetes mellitus prior RYGB operation . Serious heart respiratory illness . Haemoglobin level 6,5 mM . Healthy control subject : Have underwent bariatric surgery . Inadequate thyroid substitution , undergo treatment drug know interact Orlistat ( cyclosporine , anticoagulating agent , amiodarone , amlodipine epileptic ) , pause treatment option . Type 1 2 diabetes mellitus prior . Serious heart respiratory illness . Haemoglobin level 6,5 mM .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Glucagon-like Peptide-1</keyword>
	<keyword>Glucose-dependent insulinotropic peptide</keyword>
	<keyword>Glucagon</keyword>
	<keyword>Peptide YY 3-36</keyword>
	<keyword>Ghrelin</keyword>
	<keyword>Body Weight</keyword>
	<keyword>Obesity</keyword>
	<keyword>Overnutrition</keyword>
	<keyword>Overweight</keyword>
	<keyword>Gastrointestinal Agents</keyword>
	<keyword>GLP-1 secretagogue</keyword>
</DOC>